Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jia Hui Jane Lee"'
Autor:
Jing Lin, Jia Hui Jane Lee, Kathirvel Paramasivam, Elina Pathak, Zhenxun Wang, Zacharias Aloysius Dwi Pramono, Bing Lim, Keng Boon Wee, Uttam Surana
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 9, Iss C, Pp 263-273 (2017)
Self-renewing tumor-initiating cells (TICs) are thought to be responsible for tumor recurrence and chemo-resistance. Glycine decarboxylase, encoded by the GLDC gene, is reported to be overexpressed in TIC-enriched primary non-small-cell lung carcinom
Externí odkaz:
https://doaj.org/article/14979fe742534762afeed8b2e3cefe64
Autor:
Yong-An Lee, Chee Chong Jonathan Lek, Gao Rong, Zhengwei Wu, S Shathishwaran, Jia Hui Jane Lee, Wai Leong Tam, Torsten Wuestefeld, Sung-Jin Park, Sangyong Jung, Beomsue Kim, Nam-Young Kang, Young-Tae Chang
Publikováno v:
Theranostics. 13:1370-1380
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70cff5866f0ab03403a33e23ef69108c
https://doi.org/10.7150/thno.79282
https://doi.org/10.7150/thno.79282
Autor:
Hyung-Ho Ha, Sungjin Park, Jungyeol Lee, Xiao Liu, Nam-Young Kang, Jong-Jin Kim, Seong Soon Kim, Zhenxun Wang, Lu Wang, Haw-Young Kwon, Yong-An Lee, So Young Choi, Seong Cheol Hong, Animesh Samanta, Myung Ae Bae, Young Hyun Yu, Wai Leong Tam, Jun-Seok Lee, Young-Tae Chang, Junyoung Kim, Bing Lim, Jia Hui Jane Lee, Beomsue Kim, Dongdong Su
Publikováno v:
Journal of the American Chemical Society
Tumor initiating cells (TIC) are resistant to conventional anticancer therapy and associated with metastasis and relapse in cancer. Although various TIC markers and their antibodies have been proposed, it is limited to the use of antibodies for in vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d48e9bed7438ac152a2354b593997cb
https://pubmed.ncbi.nlm.nih.gov/31436967
https://pubmed.ncbi.nlm.nih.gov/31436967
Autor:
Jonathan Jung, Xiujun Zhang, Mervyn Zi Hao Chua, Yuanming Wang, Meng How Tan, Tianyun Zhao, Kaiwen Ivy Liu, Cheok Wei Ariel Woo, Bao Yi Chong, Ali Gowher, Guo Rong Daniel Yim, Jia Hui Jane Lee, Muhammad Nadzim Bin Ramli
Publikováno v:
Nature Chemical Biology. 12:980-987
A modified version of Cas9 with a fusion of the hormone-binding domain of the estrogen receptor allows reversible control of Cas9 activity with high efficiency at multiple loci with 4-hydroxytamoxifen treatment. CRISPR–Cas9 has emerged as a powerfu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::086209d3f37760593e45868358cbecaa
https://doi.org/10.1038/nchembio.2179
https://doi.org/10.1038/nchembio.2179
Autor:
Jia Hui Jane Lee, Jungyeol Lee, Bing Lim, Wai Leong Tam, Zhenxun Wang, Haw-Young Kwon, Yong-An Lee, Srikanta Sahu, Sungjin Park, Young-Tae Chang, Se-Young Jang, Jong-Jin Kim, Jun-Seok Lee, Nam-Young Kang
Publikováno v:
Angewandte Chemie (International ed. in English). 57(11)
Tumor initiating cells (TICs) have been implicated in clinical relapse and metastasis of a variety of epithelial cancers, including lung cancer. While efforts toward the development of specific probes for TIC detection and targeting are ongoing, a un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7da0260ed8a08ae2f57768dbc81c72b6
https://pubmed.ncbi.nlm.nih.gov/29377425
https://pubmed.ncbi.nlm.nih.gov/29377425
Autor:
Jia Hui Jane Lee, Kathirvel Paramasivam, Elina Pathak, Bing Lim, Keng Boon Wee, Jing Lin, Zacharias A.D. Pramono, Uttam Surana, Zhenxun Wang
Publikováno v:
Molecular Therapy. Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 9, Iss C, Pp 263-273 (2017)
Molecular Therapy: Nucleic Acids, Vol 9, Iss C, Pp 263-273 (2017)
Self-renewing tumor-initiating cells (TICs) are thought to be responsible for tumor recurrence and chemo-resistance. Glycine decarboxylase, encoded by the GLDC gene, is reported to be overexpressed in TIC-enriched primary non-small-cell lung carcinom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c0bf467dd0a6756e5cf513dbd9b9d3d
https://pubmed.ncbi.nlm.nih.gov/29246305
https://pubmed.ncbi.nlm.nih.gov/29246305
Autor:
Wan-Teck Lim, Jia Hui Jane Lee, Pooi Kiat William Chong, Bing Lim, Tony Kiat Hon Lim, Lian Yee Yip, Wai Leong Tam, Ju Yuan, Daniel Shao Weng Tan, Ying Swan Ho, Zhenxun Wang, Axel M. Hillmer, Eng Huat Tan, Nurhidayah Basri, Li Shi Kimberly Choo, Qiang Yu, Xia Jiang, Heather Yin Kuan Ang, Siming Ma, Kai Lay Esther Peh, Chin Chye Teo, Hui Yi Chew, Angela Takano, Zhengwei Wu
Publikováno v:
Nature medicine. 25(5)
Understanding cellular metabolism holds immense potential for developing new classes of therapeutics that target metabolic pathways in cancer. Metabolic pathways are altered in bulk neoplastic cells in comparison to normal tissues. However, carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83dd359f41840bfdc1e36712f0898348
https://pubmed.ncbi.nlm.nih.gov/31114058
https://pubmed.ncbi.nlm.nih.gov/31114058
Autor:
Zhenxun Wang, Lian Yee Yip, Daniel Shao Weng Tan, Eng Huat Tan, Siming Ma, Pooi Kiat William Chong, Chin Chye Teo, Qiang Yu, Hui Yi Chew, Bing Lim, Li Shi Kimberly Choo, Ying Swan Ho, Ju Yuan, Axel M. Hillmer, Jia Hui Jane Lee, Zhengwei Wu, Xia Jiang, Nurhidayah Basri, Angela Takano, Kai Lay Esther Peh, Heather Yin Kuan Ang, Wai Leong Tam, Wan-Teck Lim, Tony Kiat Hon Lim
Publikováno v:
Nature Medicine. 25:1022-1022
In the version of this article originally published, there is an error in Fig. 5a. Originally, 'MAT2A' appeared between 'Methionine' and 'Homocysteine'. 'MAT2A' should have been 'MTR'. The error has been corrected in the PDF and HTML versions of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0e66d4d7cb4f8a70faf2a89516710f9
https://doi.org/10.1038/s41591-019-0486-3
https://doi.org/10.1038/s41591-019-0486-3